Evaluation of community pharmacists' knowledge about drug-drug interaction in Central Saudi Arabia

被引:16
作者
Alrabiah, Ziyad [1 ]
Alhossan, Abdulaziz [1 ]
Alghadeer, Sultan M. [1 ]
Wajid, Syed [1 ]
Babelghaith, Salmeen D. [1 ]
Al-Arifi, Mohamed N. [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia
关键词
Drug-drug interaction; Community pharmacist; PATIENTS RECEIVING INHIBITORS; EMERGENCY-DEPARTMENT VISITS; INTERACTION ALERTS; COTRIMOXAZOLE; MEDICATIONS; THERAPY; EVENTS; IMPACT; AGENTS; RISK;
D O I
10.1016/j.jsps.2019.01.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Although all implemented and ongoing initiatives, drug-drug interactions (DDIs) are still a global problem. Most published studies about DDIs in Saudi Arabia are carried out in hospital settings. In addition, assessing the knowledge of drug interactions in Saudi Arabia is limited. The aim of our study is to evaluate the knowledge of potential common drug-drug interactions among community pharmacists particularly in Saudi Arabia. Methodology: A crosses-sectional study utilizing a self-administered questionnaire was conducted among community pharmacy in Riyadh city Saudi Arabia. DDIs' knowledge was assessed by 26 drug pairs. Community pharmacists were asked to select the DDIs as "contraindication", "may be used together with monitoring", "no interaction" and "not sure". Results: A total of 283 of community pharmacists completed the survey with response rate of 80.9%. Among the 26 drug pairs only 5 of them were identified correctly by most of the participants. To add more 3 out of the 5 pairs had a cutoff of less than 10% between the correct and wrong answer, meaning there still a majority that couldn't identify the correct answer. All the 26 pairs had a statistically significant difference between the correct and incorrect answer. Conclusion: The results of this study showed that knowledge of community pharmacists about DDIs was inadequate. Community pharmacist should have specific courses in drug interactions to cover the most possible interactions that can be seen in this setting. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:463 / 466
页数:4
相关论文
共 30 条
[1]   Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia [J].
Al-Arifi, Mohamed ;
Abu-Hashem, Hanan ;
Al-Meziny, Mohamed ;
Said, Ragab ;
Aljadhey, Hisham .
SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (01) :17-25
[2]   Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia [J].
Al-Arifi, Mohamed N. .
SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (04) :351-360
[3]   Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study [J].
Antoniou, Tony ;
Gomes, Tara ;
Mamdani, Muhammad M. ;
Yao, Zhan ;
Hellings, Chelsea ;
Garg, Amit X. ;
Weir, Matthew A. ;
Juurlink, David N. .
BRITISH MEDICAL JOURNAL, 2011, 343
[4]   Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study [J].
Antoniou, Tony ;
Gomes, Tara ;
Mamdani, Muhammad M. ;
Juurlink, David N. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) :544-549
[5]   Trimethoprim-Sulfamethoxazole-Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System A Population-Based Study [J].
Antoniou, Tony ;
Gomes, Tara ;
Juurlink, David N. ;
Loutfy, Mona R. ;
Glazier, Richard H. ;
Mamdani, Muhammad M. .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (12) :1045-1049
[6]   Hospitalisations and emergency department visits due to drug-drug interactions: a literature review [J].
Becker, Matthijs L. ;
Kallewaard, Marjon ;
Caspers, Peter W. J. ;
Visser, Loes E. ;
Leufkens, Hubert G. M. ;
Stricker, Bruno HCh .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (06) :641-651
[7]   ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J].
Bhatt, Deepak L. ;
Scheiman, James ;
Abraham, Neena S. ;
Antman, Elliott M. ;
Chan, Francis K. L. ;
Furberg, Curt D. ;
Johnson, David A. ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bridges, Charles R. ;
Eisenberg, Mark J. ;
Ferrari, Victor A. ;
Hlatky, Mark A. ;
Kaul, Sanjay ;
Lindner, Jonathan R. ;
Moliterno, David J. ;
Mukherjee, Debabrata ;
Schofield, Richard S. ;
Rosenson, Robert S. ;
Stein, James H. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) :1502-1517
[8]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[9]   Coadministration of Oral Levofloxacin With Agents That Impair Absorption: Impact on Antibiotic Resistance [J].
Cohen, Keira A. ;
Lautenbach, Ebbing ;
Weiner, Mark G. ;
Synnestvedt, Marie ;
Gasink, Leanne B. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (10) :975-977
[10]   Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding [J].
Delaney, Joseph A. ;
Opatrny, Lucie ;
Brophy, James M. ;
Suissa, Samy .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (04) :347-351